| . | PLWHIV . | Controls . |
|---|---|---|
| . | N=173 712 . | N = 173 712 . |
| Age at index date | ||
| Mean (SD) | 41.8 (11.4) | 41.8 (11.4) |
| Median/min/max | 41.0/18.0/98.0 | 41.0/18.0/98.0 |
| Quartile 25/quartile 75 | 34.0/48.0 | 34.0/48.0 |
| Gender | ||
| Men | 115 603 (66.5%) | 115 603 (66.5%) |
| Women | 58 109 (33.5%) | 58 109 (33.5%) |
| Covered by the CMU-c at the index date | ||
| No | 135 596 (78.1%) | 165 968 (95.5%) |
| Yes | 38 116 (21.9%) | 7744 (4.5%) |
| Covered by the AME at the index date | ||
| No | 168 461 (97.0%) | 172 931 (99.6%) |
| Yes | 5251 (3.0%) | 781 (0.4%) |
| Region of residency | ||
| ND | 1616 | 808 |
| Grand-Est | 8269 (4.8%) | 13 334 (7.7%) |
| Nouvelle-Aquitaine | 12 392 (7.2%) | 15 663 (9.1%) |
| Auvergne-Rhone-Alpes | 13 304 (7.7%) | 19 609 (11.3%) |
| Bourgogne-Franche-Comte | 3685 (2.1%) | 6612 (3.8%) |
| Bretagne | 5116 (3.0%) | 8235 (4.8%) |
| Centre-Val-de-Loire | 4932 (2.9%) | 6518 (3.8%) |
| Ile de France | 65 829 (38.3%) | 36 270 (21.0%) |
| Occitanie | 14 293 (8.3%) | 15 811 (9.1%) |
| Hauts-de-France | 6877 (4.0%) | 13 449 (7.8%) |
| Normandie | 4994 (2.9%) | 7962 (4.6%) |
| Pays de la Loire | 6203 (3.6%) | 8912 (5.2%) |
| Provence-Alpes-Cote d'Azur + Corse | 17 623 (10.2%) | 15 182 (8.8%) |
| TOM | 8574 (5.0%) | 5335 (3.1%) |
| Pays Etrangers | 5 (0.0%) | 12 (0.0%) |
| Ischemic cardiopathy | 15 149 (8.7%) | 7073 (4.1%) |
| Unstable angina | 3330 (1.9%) | 1723 (1.0%) |
| Myocardial infarction | 4232 (2.4%) | 2277 (1.3%) |
| Ischemic heart disease | 14 210 (8.2%) | 6316 (3.6%) |
| Percutaneous revascularization of the coronary arteries | 6465 (3.7%) | 3689 (2.1%) |
| Stroke and transit ischemic attacks | 5182 (3.0%) | 2800 (1.6%) |
| Stroke (history of) | 4226 (2.4%) | 2044 (1.2%) |
| Transit ischemic attacks (history of) | 1454 (0.8%) | 1013 (0.6%) |
| Heart failure | 6212 (3.6%) | 2824 (1.6%) |
| Peripheral artery disease | 5321 (3.1%) | 2548 (1.5%) |
| Hypertension | 46 150 (26.6%) | 33 992 (19.6%) |
| Dyslipidemia | 28 664 (16.5%) | 24 221 (13.9%) |
| Thrombo-embolic events | 3649 (2.1%) | 1557 (0.9%) |
| pulmonary embolism | 2805 (1.6%) | 1130 (0.7%) |
| Respiratory obstructive diseases | 29 155 (16.8%) | 17 522 (10.1%) |
| Diabetes | 16 460 (9.5%) | 12 196 (7.0%) |
| Hepatitis C | 22 447 (12.9%) | 840 (0.5%) |
| Hepatitis CB | 9905 (5.7%) | 324 (0.2%) |
| Infectious diseases (history of) | 66 536 (38.3%) | 14 041 (8.1%) |
| Cancer | 11 605 (6.7%) | 9020 (5.2%) |
| Kidney diseases and/or end stage kidney disease | 2339 (1.3%) | 703 (0.4%) |
| Kidney diseases | 1878 (1.1%) | 638 (0.4%) |
| Mood disorders | 47 474 (27.3%) | 26 771 (15.4%) |
| Neurotic disorders | 53 314 (30.7%) | 30 457 (17.5%) |
| Mental and behavioral disorders due to psychoactive substance use | 23 454 (13.5%) | 7475 (4.3%) |
| . | PLWHIV . | Controls . |
|---|---|---|
| . | N=173 712 . | N = 173 712 . |
| Age at index date | ||
| Mean (SD) | 41.8 (11.4) | 41.8 (11.4) |
| Median/min/max | 41.0/18.0/98.0 | 41.0/18.0/98.0 |
| Quartile 25/quartile 75 | 34.0/48.0 | 34.0/48.0 |
| Gender | ||
| Men | 115 603 (66.5%) | 115 603 (66.5%) |
| Women | 58 109 (33.5%) | 58 109 (33.5%) |
| Covered by the CMU-c at the index date | ||
| No | 135 596 (78.1%) | 165 968 (95.5%) |
| Yes | 38 116 (21.9%) | 7744 (4.5%) |
| Covered by the AME at the index date | ||
| No | 168 461 (97.0%) | 172 931 (99.6%) |
| Yes | 5251 (3.0%) | 781 (0.4%) |
| Region of residency | ||
| ND | 1616 | 808 |
| Grand-Est | 8269 (4.8%) | 13 334 (7.7%) |
| Nouvelle-Aquitaine | 12 392 (7.2%) | 15 663 (9.1%) |
| Auvergne-Rhone-Alpes | 13 304 (7.7%) | 19 609 (11.3%) |
| Bourgogne-Franche-Comte | 3685 (2.1%) | 6612 (3.8%) |
| Bretagne | 5116 (3.0%) | 8235 (4.8%) |
| Centre-Val-de-Loire | 4932 (2.9%) | 6518 (3.8%) |
| Ile de France | 65 829 (38.3%) | 36 270 (21.0%) |
| Occitanie | 14 293 (8.3%) | 15 811 (9.1%) |
| Hauts-de-France | 6877 (4.0%) | 13 449 (7.8%) |
| Normandie | 4994 (2.9%) | 7962 (4.6%) |
| Pays de la Loire | 6203 (3.6%) | 8912 (5.2%) |
| Provence-Alpes-Cote d'Azur + Corse | 17 623 (10.2%) | 15 182 (8.8%) |
| TOM | 8574 (5.0%) | 5335 (3.1%) |
| Pays Etrangers | 5 (0.0%) | 12 (0.0%) |
| Ischemic cardiopathy | 15 149 (8.7%) | 7073 (4.1%) |
| Unstable angina | 3330 (1.9%) | 1723 (1.0%) |
| Myocardial infarction | 4232 (2.4%) | 2277 (1.3%) |
| Ischemic heart disease | 14 210 (8.2%) | 6316 (3.6%) |
| Percutaneous revascularization of the coronary arteries | 6465 (3.7%) | 3689 (2.1%) |
| Stroke and transit ischemic attacks | 5182 (3.0%) | 2800 (1.6%) |
| Stroke (history of) | 4226 (2.4%) | 2044 (1.2%) |
| Transit ischemic attacks (history of) | 1454 (0.8%) | 1013 (0.6%) |
| Heart failure | 6212 (3.6%) | 2824 (1.6%) |
| Peripheral artery disease | 5321 (3.1%) | 2548 (1.5%) |
| Hypertension | 46 150 (26.6%) | 33 992 (19.6%) |
| Dyslipidemia | 28 664 (16.5%) | 24 221 (13.9%) |
| Thrombo-embolic events | 3649 (2.1%) | 1557 (0.9%) |
| pulmonary embolism | 2805 (1.6%) | 1130 (0.7%) |
| Respiratory obstructive diseases | 29 155 (16.8%) | 17 522 (10.1%) |
| Diabetes | 16 460 (9.5%) | 12 196 (7.0%) |
| Hepatitis C | 22 447 (12.9%) | 840 (0.5%) |
| Hepatitis CB | 9905 (5.7%) | 324 (0.2%) |
| Infectious diseases (history of) | 66 536 (38.3%) | 14 041 (8.1%) |
| Cancer | 11 605 (6.7%) | 9020 (5.2%) |
| Kidney diseases and/or end stage kidney disease | 2339 (1.3%) | 703 (0.4%) |
| Kidney diseases | 1878 (1.1%) | 638 (0.4%) |
| Mood disorders | 47 474 (27.3%) | 26 771 (15.4%) |
| Neurotic disorders | 53 314 (30.7%) | 30 457 (17.5%) |
| Mental and behavioral disorders due to psychoactive substance use | 23 454 (13.5%) | 7475 (4.3%) |
| . | PLWHIV . | Controls . |
|---|---|---|
| . | N=173 712 . | N = 173 712 . |
| Age at index date | ||
| Mean (SD) | 41.8 (11.4) | 41.8 (11.4) |
| Median/min/max | 41.0/18.0/98.0 | 41.0/18.0/98.0 |
| Quartile 25/quartile 75 | 34.0/48.0 | 34.0/48.0 |
| Gender | ||
| Men | 115 603 (66.5%) | 115 603 (66.5%) |
| Women | 58 109 (33.5%) | 58 109 (33.5%) |
| Covered by the CMU-c at the index date | ||
| No | 135 596 (78.1%) | 165 968 (95.5%) |
| Yes | 38 116 (21.9%) | 7744 (4.5%) |
| Covered by the AME at the index date | ||
| No | 168 461 (97.0%) | 172 931 (99.6%) |
| Yes | 5251 (3.0%) | 781 (0.4%) |
| Region of residency | ||
| ND | 1616 | 808 |
| Grand-Est | 8269 (4.8%) | 13 334 (7.7%) |
| Nouvelle-Aquitaine | 12 392 (7.2%) | 15 663 (9.1%) |
| Auvergne-Rhone-Alpes | 13 304 (7.7%) | 19 609 (11.3%) |
| Bourgogne-Franche-Comte | 3685 (2.1%) | 6612 (3.8%) |
| Bretagne | 5116 (3.0%) | 8235 (4.8%) |
| Centre-Val-de-Loire | 4932 (2.9%) | 6518 (3.8%) |
| Ile de France | 65 829 (38.3%) | 36 270 (21.0%) |
| Occitanie | 14 293 (8.3%) | 15 811 (9.1%) |
| Hauts-de-France | 6877 (4.0%) | 13 449 (7.8%) |
| Normandie | 4994 (2.9%) | 7962 (4.6%) |
| Pays de la Loire | 6203 (3.6%) | 8912 (5.2%) |
| Provence-Alpes-Cote d'Azur + Corse | 17 623 (10.2%) | 15 182 (8.8%) |
| TOM | 8574 (5.0%) | 5335 (3.1%) |
| Pays Etrangers | 5 (0.0%) | 12 (0.0%) |
| Ischemic cardiopathy | 15 149 (8.7%) | 7073 (4.1%) |
| Unstable angina | 3330 (1.9%) | 1723 (1.0%) |
| Myocardial infarction | 4232 (2.4%) | 2277 (1.3%) |
| Ischemic heart disease | 14 210 (8.2%) | 6316 (3.6%) |
| Percutaneous revascularization of the coronary arteries | 6465 (3.7%) | 3689 (2.1%) |
| Stroke and transit ischemic attacks | 5182 (3.0%) | 2800 (1.6%) |
| Stroke (history of) | 4226 (2.4%) | 2044 (1.2%) |
| Transit ischemic attacks (history of) | 1454 (0.8%) | 1013 (0.6%) |
| Heart failure | 6212 (3.6%) | 2824 (1.6%) |
| Peripheral artery disease | 5321 (3.1%) | 2548 (1.5%) |
| Hypertension | 46 150 (26.6%) | 33 992 (19.6%) |
| Dyslipidemia | 28 664 (16.5%) | 24 221 (13.9%) |
| Thrombo-embolic events | 3649 (2.1%) | 1557 (0.9%) |
| pulmonary embolism | 2805 (1.6%) | 1130 (0.7%) |
| Respiratory obstructive diseases | 29 155 (16.8%) | 17 522 (10.1%) |
| Diabetes | 16 460 (9.5%) | 12 196 (7.0%) |
| Hepatitis C | 22 447 (12.9%) | 840 (0.5%) |
| Hepatitis CB | 9905 (5.7%) | 324 (0.2%) |
| Infectious diseases (history of) | 66 536 (38.3%) | 14 041 (8.1%) |
| Cancer | 11 605 (6.7%) | 9020 (5.2%) |
| Kidney diseases and/or end stage kidney disease | 2339 (1.3%) | 703 (0.4%) |
| Kidney diseases | 1878 (1.1%) | 638 (0.4%) |
| Mood disorders | 47 474 (27.3%) | 26 771 (15.4%) |
| Neurotic disorders | 53 314 (30.7%) | 30 457 (17.5%) |
| Mental and behavioral disorders due to psychoactive substance use | 23 454 (13.5%) | 7475 (4.3%) |
| . | PLWHIV . | Controls . |
|---|---|---|
| . | N=173 712 . | N = 173 712 . |
| Age at index date | ||
| Mean (SD) | 41.8 (11.4) | 41.8 (11.4) |
| Median/min/max | 41.0/18.0/98.0 | 41.0/18.0/98.0 |
| Quartile 25/quartile 75 | 34.0/48.0 | 34.0/48.0 |
| Gender | ||
| Men | 115 603 (66.5%) | 115 603 (66.5%) |
| Women | 58 109 (33.5%) | 58 109 (33.5%) |
| Covered by the CMU-c at the index date | ||
| No | 135 596 (78.1%) | 165 968 (95.5%) |
| Yes | 38 116 (21.9%) | 7744 (4.5%) |
| Covered by the AME at the index date | ||
| No | 168 461 (97.0%) | 172 931 (99.6%) |
| Yes | 5251 (3.0%) | 781 (0.4%) |
| Region of residency | ||
| ND | 1616 | 808 |
| Grand-Est | 8269 (4.8%) | 13 334 (7.7%) |
| Nouvelle-Aquitaine | 12 392 (7.2%) | 15 663 (9.1%) |
| Auvergne-Rhone-Alpes | 13 304 (7.7%) | 19 609 (11.3%) |
| Bourgogne-Franche-Comte | 3685 (2.1%) | 6612 (3.8%) |
| Bretagne | 5116 (3.0%) | 8235 (4.8%) |
| Centre-Val-de-Loire | 4932 (2.9%) | 6518 (3.8%) |
| Ile de France | 65 829 (38.3%) | 36 270 (21.0%) |
| Occitanie | 14 293 (8.3%) | 15 811 (9.1%) |
| Hauts-de-France | 6877 (4.0%) | 13 449 (7.8%) |
| Normandie | 4994 (2.9%) | 7962 (4.6%) |
| Pays de la Loire | 6203 (3.6%) | 8912 (5.2%) |
| Provence-Alpes-Cote d'Azur + Corse | 17 623 (10.2%) | 15 182 (8.8%) |
| TOM | 8574 (5.0%) | 5335 (3.1%) |
| Pays Etrangers | 5 (0.0%) | 12 (0.0%) |
| Ischemic cardiopathy | 15 149 (8.7%) | 7073 (4.1%) |
| Unstable angina | 3330 (1.9%) | 1723 (1.0%) |
| Myocardial infarction | 4232 (2.4%) | 2277 (1.3%) |
| Ischemic heart disease | 14 210 (8.2%) | 6316 (3.6%) |
| Percutaneous revascularization of the coronary arteries | 6465 (3.7%) | 3689 (2.1%) |
| Stroke and transit ischemic attacks | 5182 (3.0%) | 2800 (1.6%) |
| Stroke (history of) | 4226 (2.4%) | 2044 (1.2%) |
| Transit ischemic attacks (history of) | 1454 (0.8%) | 1013 (0.6%) |
| Heart failure | 6212 (3.6%) | 2824 (1.6%) |
| Peripheral artery disease | 5321 (3.1%) | 2548 (1.5%) |
| Hypertension | 46 150 (26.6%) | 33 992 (19.6%) |
| Dyslipidemia | 28 664 (16.5%) | 24 221 (13.9%) |
| Thrombo-embolic events | 3649 (2.1%) | 1557 (0.9%) |
| pulmonary embolism | 2805 (1.6%) | 1130 (0.7%) |
| Respiratory obstructive diseases | 29 155 (16.8%) | 17 522 (10.1%) |
| Diabetes | 16 460 (9.5%) | 12 196 (7.0%) |
| Hepatitis C | 22 447 (12.9%) | 840 (0.5%) |
| Hepatitis CB | 9905 (5.7%) | 324 (0.2%) |
| Infectious diseases (history of) | 66 536 (38.3%) | 14 041 (8.1%) |
| Cancer | 11 605 (6.7%) | 9020 (5.2%) |
| Kidney diseases and/or end stage kidney disease | 2339 (1.3%) | 703 (0.4%) |
| Kidney diseases | 1878 (1.1%) | 638 (0.4%) |
| Mood disorders | 47 474 (27.3%) | 26 771 (15.4%) |
| Neurotic disorders | 53 314 (30.7%) | 30 457 (17.5%) |
| Mental and behavioral disorders due to psychoactive substance use | 23 454 (13.5%) | 7475 (4.3%) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
